HDAC6-IN-8

This compound series features both broad-spectrum and isoform-selective HDAC inhibitors. Compound 12C acts as a pan-HDAC inhibitor, while analogs 9m and 9q demonstrate preferential activity against HDAC6. These small molecules are valuable tools for epigenetic research in oncology and neurology, suitable for both in vitro enzymatic studies and cellular mechanism investigations.